{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-031068","form_type":"8-K","ticker":null,"cik":"0000727207","company_name":"Accelerate Diagnostics, Inc","filed_at":"2024-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.771965+00:00","generated_at":"2026-06-05T04:24:10.884876+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"AXDX receives Nasdaq delisting notice for MVLS below $35M; 180-day cure period","bullets":["Market Value of Listed Securities was below $35M for 31 consecutive business days.","Company has until September 3, 2024 to regain compliance by closing at $35M+ for 10 days.","May also consider increasing stockholders' equity to at least $2.5M to comply.","Notice does not immediately delist stock; failure to cure may lead to delisting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-031068","json":"https://secwatch.observer/filing/0001104659-24-031068.json","markdown":"https://secwatch.observer/filing/0001104659-24-031068.md","text":"https://secwatch.observer/filing/0001104659-24-031068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/727207/000110465924031068/0001104659-24-031068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/727207/000110465924031068/tm247980d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T04:24:10.884876+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"73b355f8288b9221b94e763d386dadfd3ca4d1b3","claim":"Accelerate Diagnostics, Inc received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).","evidence_excerpt":"March 4, 2024, Accelerate Diagnostics, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 31 consecutive business days prior to the date of the Notice, the Company’s Market Value of Listed Securities (as defined under Nasdaq rules) was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), Nasd","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924031068/0001104659-24-031068-index.htm","confidence":0.96,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5550(b)(2), 5810(c)(3)(C)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}